Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Likarda Receives Gates Foundation Grant to Support its Core-Shell Spherification System | ||
Mo | OFD Life Sciences Announces Leadership Changes | ||
Mo | J&J Ups U.S. Investment to More Than $55B | ||
Mo | Novo Nordisk Secures Triple Agonist UBT251 in $2B Deal | ||
Mo | Everest Medicine's IND Application for EVM14 Cleared by FDA | ||
Mo | Pathios Therapeutics Names Sumeet Ambarkhane as Chief Medical Officer | ||
Fr | Roche & Oxford BioTherapeutics Partner on Novel Cancer Therapies | ||
Fr | Sanofi to Acquire DR-0201 from Dren Bio | ||
Fr | Syneron Bio, AstraZeneca Partner to Develop Macrocyclic Peptides | ||
Fr | Wheeler Bio Closes $35M Series A-1 Financing Round | ||
Do | Life Sciences Lead the Way in Pittsburgh's Tech Ecosystem | ||
Do | Akari Therapeutics Appoints Abizer Gaslightwala President and CEO | ||
Do | Grifols, Inpeco Partner to Modernize Lab Operations | ||
Do | Coronado Research Appoints Gary Lyons as EVP of Medical Affairs | ||
Do | Bristol Myers Squibb Names GM for Saudi Arabia and Gulf Countries | ||
Mi | Sobi Enters Research Collaboration for Development of Gamifant in Sepsis | ||
Mi | OPKO Health, Entera Bio Partner on Oral Dual Agonist GLP-1 | ||
Mi | Advanced Instruments to Acquire and Merge with Nova Biomedical | ||
18.03. | Delpharm to Modernize Its Injectable Manufacturing Facility in Boucherville | ||
18.03. | Huyabio Taps Paul Spreen as Chief Business Officer | ||
18.03. | Kincell Bio Appoints Larry Pitcher as COO | ||
17.03. | Taiho to Acquire Araris Biotech in Potential $1.1B Deal | ||
17.03. | AstraZeneca, Alteogen Enter License Agreement for Subcutaneous Formulations of Oncology Assets | ||
17.03. | iOncologi Acquires TargImmune Therapeutics | ||
17.03. | ChromaTan and Landmark Bio Receive NIIMBL Grant |